Human babesiosis is an emerging tick‐borne infectious disease caused by intraerythrocytic protozoan parasites of the genus Babesia. The disease is named after Victor Babes, a renowned 19th‐century microbiologist and pathologist who first discovered the causative pathogen in Romanian cattle in 1888. The first case of human babesiosis was reported in a Yugoslavian farmer in 1957. A decade later, the first case of babesiosis in an immunocompetent person was described on Nantucket Island, Massachusetts, which soon became the first area recognized as endemic for the disease in humans. It was here that the endemic cycle was first described, including the causative pathogen, Babesia microti; the tick vector, Ixodes dammini or deer tick (subsequently renamed Ixodes scapularis or black‐legged tick); and the reservoir host, Peromyscus leucopus (white‐footed mouse). The same tick vector was subsequently found to transmit the agent of Lyme disease (Borrelia burgdorferi), a disease first described in 1977. Babesiosis and Lyme disease have spread across the northeastern and upper Midwestern United States but Lyme disease has been predominant in both number of cases and geographic range. Clinical and research interest therefore focused on Lyme disease, while babesiosis was viewed somewhat as a medical curiosity. This perception began to change
Transfusion – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera